Foresight Diagnostics (Foresight) today revealed new data from its ultra-sensitive Foresight CLARITY™ minimal residual disease (MRD) platform in early-stage breast cancer, which will be presented at the 2024 San Antonio Breast Cancer Symposium (SABCS) later this month. Foresight Diagnostics and…
Anteris Technologies Global Corp. (“ATGC”) announced today that it has filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for the proposed initial public offering (IPO) of its common stock in the U.S. (the…
Vaxxas, a clinical-stage biotech company, has broadened its global intellectual property portfolio to include 42 patents, reinforcing its exclusive rights to manufacture and sell its proprietary high-density microarray patch (HD-MAP) vaccination technology across the United States, Europe, Asia, and Australia.…
Meridian Health Plan of Illinois, a leading provider of government-sponsored managed care services, has announced a strategic partnership with Liberty Bank and Trust to create a small business loan program aimed at empowering diverse and minority-owned businesses in Illinois. This…
HCA Healthcare, Inc. (NYSE:HCA), one of the largest healthcare providers in the United States, proudly announced the success of its sixth annual “Crush the Crisis” national prescription drug take-back day, collecting a record-breaking 21,137 pounds of unused or expired medications.…
CVS Health has made history as the first healthcare company to earn accreditation for Health Equity from URAC, a distinction granted for the impactful work carried out through CVS Caremark and CVS Specialty. URAC, an organization that sets high standards…
CVS Health® (NYSE: CVS) has announced that Dr. Sreekanth Chaguturu, currently serving as executive vice president and chief medical officer of CVS Health, will take on an expanded role as president of Health Care Delivery. Dr. Chaguturu succeeds Mike Pykosz,…
The Children’s Inn at the National Institutes of Health (NIH) has announced that Gilead Sciences Inc. has awarded a $1 million grant to support its ongoing renovation and expansion efforts. This funding will specifically be used to create a welcome…
The BioFuture™ 2024 conference, organized by Demy-Colton, concluded in New York and virtually, marking the largest turnout in the event’s history. This year’s conference brought together more than 100 speakers, over 100 investors, 62 presenting companies, and 48 journalists, all…
OverT Bio, a cell therapy company based in New York City, has announced it has received a $120,000 G-Rex Grant from ScaleReady™, in partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™. The grant will support OverT Bio’s…
GE HealthCare (Nasdaq: GEHC) has introduced new clinical applications to its OEC 3D mobile CBCT C-arm portfolio, designed to enhance precise and efficient imaging during endoscopic bronchoscopy procedures in interventional pulmonology. Complex pulmonary and thoracic procedures require precise intraoperative imaging…
During Pulmonary Hypertension Awareness Month, two European studies emphasize the urgent need for improved diagnosis and treatment of pulmonary hypertension linked to interstitial lung disease. Pulmonary Hypertension (PH) is a condition characterized by high blood pressure in the pulmonary arteries,…